Drug Trial Radar · NCT03664752
Study Comparing the Safety and Efficacy of IDP-120 Gel and IDP-120 Vehicle Gel in the Treatment of Participants With Acne Vulgaris
Last checked: Nov 20, 2026Latest source record: Oct 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
585
Actual
Start
Dec 10, 2018
Primary completion
May 7, 2020
Study completion May 7, 2020
Sponsor
- Lead sponsor
- Bausch Health Americas, Inc.Industry
- Sponsor type
- Industry
- First posted
- Sep 10, 2018
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 9 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
study designed to assess the safety, tolerability, and efficacy of IDP-120 Gel and IDP-120 Vehicle Gel
Conditions
- Acne Vulgaris
Interventions
IDP-120 GelDrug
IDP-120 Gel, once-daily application
IDP-120 Vehicle GelDrug
IDP-120 Vehicle Gel, once-daily application
Primary outcomes
What the sponsor says the trial is designed to measure.
- Absolute Change in Mean Lesion Counts at Week 12Time frame: Baseline to Week 12
- Percentage of Subjects Who Had at Least a 2-grade Reduction From Baseline at Week 12 in the Evaluator's Global Severity Score (EGSS) and Had an EGSS at Week 12 That Equated to "Clear" or "Almost Clear"Time frame: Baseline to Week 12
Locations
20 sites in 2 countries. Site status is shown where the registry gives one.
Valeant Site 210
Rogers, Arkansas
Valeant Site 201
Manhattan Beach, California
Valeant Site 206
San Diego, California
Valeant Site 218
San Diego, California
Valeant Site 204
Boynton Beach, Florida
Valeant Site 217
Brandon, Florida
Valeant Site 202S
Miami, Florida
Valeant Site 214
Tampa, Florida
Valeant Site 222
Snellville, Georgia
Valeant Site 215
Boise, Idaho
Valeant Site 205
Metairie, Louisiana
Valeant Site 216
Clarkston, Michigan
Valeant Site 221
Clinton Township, Michigan
Valeant Site 227
Rochester, New York
Valeant Site 229
Raleigh, North Carolina
Valeant Site 230
Raleigh, North Carolina
Valeant Site 213
San Antonio, Texas
Valeant Site 223
Spokane, Washington
Valeant Site 219
Waterloo, Ontario, Canada
Valeant Site 228
Waterloo, Ontario, Canada
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.